IL17A and myeloid sarcoma: What is interesting is that we observed significant difference in the percentage of IL-17-positive T-cells in the MS patients group between cells pulsed with exosomes from resting astrocytes and exosomes isolated from TGF-β primed astrocytes (Figure 4A).